Logo image of MNTK

MONTAUK RENEWABLES INC (MNTK) Stock Fundamental Analysis

NASDAQ:MNTK - Nasdaq - US61218C1036 - Common Stock - Currency: USD

2.24  +0.04 (+1.82%)

After market: 2.24 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MNTK. MNTK was compared to 21 industry peers in the Independent Power and Renewable Electricity Producers industry. Both the profitability and the financial health of MNTK get a neutral evaluation. Nothing too spectacular is happening here. MNTK has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

MNTK had positive earnings in the past year.
MNTK had a positive operating cash flow in the past year.
MNTK had positive earnings in 4 of the past 5 years.
Each year in the past 5 years MNTK had a positive operating cash flow.
MNTK Yearly Net Income VS EBIT VS OCF VS FCFMNTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M 80M

1.2 Ratios

The Return On Assets of MNTK (2.79%) is better than 76.19% of its industry peers.
With a decent Return On Equity value of 3.78%, MNTK is doing good in the industry, outperforming 61.90% of the companies in the same industry.
The Return On Invested Capital of MNTK (4.54%) is better than 85.71% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MNTK is above the industry average of 3.62%.
Industry RankSector Rank
ROA 2.79%
ROE 3.78%
ROIC 4.54%
ROA(3y)5.88%
ROA(5y)3.58%
ROE(3y)8.42%
ROE(5y)5.13%
ROIC(3y)7.97%
ROIC(5y)5.37%
MNTK Yearly ROA, ROE, ROICMNTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

MNTK has a Profit Margin (5.54%) which is comparable to the rest of the industry.
MNTK's Profit Margin has been stable in the last couple of years.
MNTK has a Operating Margin of 10.11%. This is comparable to the rest of the industry: MNTK outperforms 52.38% of its industry peers.
MNTK's Operating Margin has declined in the last couple of years.
The Gross Margin of MNTK (44.14%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of MNTK has remained more or less at the same level.
Industry RankSector Rank
OM 10.11%
PM (TTM) 5.54%
GM 44.14%
OM growth 3Y45.12%
OM growth 5Y-4.7%
PM growth 3YN/A
PM growth 5Y0.19%
GM growth 3Y-2.25%
GM growth 5Y-0.15%
MNTK Yearly Profit, Operating, Gross MarginsMNTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MNTK is destroying value.
The number of shares outstanding for MNTK has been increased compared to 1 year ago.
Compared to 5 years ago, MNTK has more shares outstanding
Compared to 1 year ago, MNTK has an improved debt to assets ratio.
MNTK Yearly Shares OutstandingMNTK Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M
MNTK Yearly Total Debt VS Total AssetsMNTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

MNTK has an Altman-Z score of 3.04. This indicates that MNTK is financially healthy and has little risk of bankruptcy at the moment.
MNTK has a better Altman-Z score (3.04) than 90.48% of its industry peers.
MNTK has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
MNTK has a Debt to Equity ratio of 0.17. This is amongst the best in the industry. MNTK outperforms 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 3.04
ROIC/WACC0.53
WACC8.54%
MNTK Yearly LT Debt VS Equity VS FCFMNTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

2.3 Liquidity

A Current Ratio of 1.71 indicates that MNTK should not have too much problems paying its short term obligations.
MNTK has a Current ratio of 1.71. This is amongst the best in the industry. MNTK outperforms 80.95% of its industry peers.
MNTK has a Quick Ratio of 1.71. This is a normal value and indicates that MNTK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.71, MNTK belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.71
Quick Ratio 1.71
MNTK Yearly Current Assets VS Current LiabilitesMNTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for MNTK have decreased strongly by -40.00% in the last year.
MNTK shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.33% yearly.
Looking at the last year, MNTK shows a small growth in Revenue. The Revenue has grown by 0.47% in the last year.
The Revenue has been growing by 10.70% on average over the past years. This is quite good.
EPS 1Y (TTM)-40%
EPS 3YN/A
EPS 5Y11.33%
EPS Q2Q%-300%
Revenue 1Y (TTM)0.47%
Revenue growth 3Y5.87%
Revenue growth 5Y10.7%
Sales Q2Q%-40.83%

3.2 Future

Based on estimates for the next years, MNTK will show a very strong growth in Earnings Per Share. The EPS will grow by 20.59% on average per year.
The Revenue is expected to grow by 9.17% on average over the next years. This is quite good.
EPS Next Y44.5%
EPS Next 2Y48.66%
EPS Next 3Y51.2%
EPS Next 5Y20.59%
Revenue Next Year-12.11%
Revenue Next 2Y4.12%
Revenue Next 3Y9.17%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MNTK Yearly Revenue VS EstimatesMNTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
MNTK Yearly EPS VS EstimatesMNTK Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 0.1 0.2 0.3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 37.33, MNTK can be considered very expensive at the moment.
66.67% of the companies in the same industry are more expensive than MNTK, based on the Price/Earnings ratio.
MNTK is valuated rather expensively when we compare the Price/Earnings ratio to 28.64, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 25.84, the valuation of MNTK can be described as expensive.
Based on the Price/Forward Earnings ratio, MNTK is valued cheaper than 80.95% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of MNTK to the average of the S&P500 Index (21.44), we can say MNTK is valued slightly more expensively.
Industry RankSector Rank
PE 37.33
Fwd PE 25.84
MNTK Price Earnings VS Forward Price EarningsMNTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200

4.2 Price Multiples

MNTK's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MNTK is cheaper than 95.24% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 7.88
MNTK Per share dataMNTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

MNTK's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MNTK has a very decent profitability rating, which may justify a higher PE ratio.
MNTK's earnings are expected to grow with 51.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.84
PEG (5Y)3.3
EPS Next 2Y48.66%
EPS Next 3Y51.2%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MNTK!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MONTAUK RENEWABLES INC

NASDAQ:MNTK (4/23/2025, 8:22:43 PM)

After market: 2.24 0 (0%)

2.24

+0.04 (+1.82%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)03-13 2025-03-13/bmo
Earnings (Next)05-07 2025-05-07/amc
Inst Owners16.91%
Inst Owner Change0.24%
Ins Owners54.03%
Ins Owner Change0%
Market Cap321.08M
Analysts48.89
Price Target3.83 (70.98%)
Short Float %2.94%
Short Ratio8.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-100%
Min EPS beat(2)-223.84%
Max EPS beat(2)23.84%
EPS beat(4)2
Avg EPS beat(4)-54.61%
Min EPS beat(4)-223.84%
Max EPS beat(4)96.08%
EPS beat(8)2
Avg EPS beat(8)-69.25%
EPS beat(12)2
Avg EPS beat(12)-62.8%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-23%
Min Revenue beat(2)-51.79%
Max Revenue beat(2)5.8%
Revenue beat(4)1
Avg Revenue beat(4)-17.72%
Min Revenue beat(4)-51.79%
Max Revenue beat(4)5.8%
Revenue beat(8)2
Avg Revenue beat(8)-16.98%
Revenue beat(12)3
Avg Revenue beat(12)-12.39%
Revenue beat(16)7
Avg Revenue beat(16)-5.42%
PT rev (1m)0%
PT rev (3m)-36.84%
EPS NQ rev (1m)174.99%
EPS NQ rev (3m)350%
EPS NY rev (1m)-51.43%
EPS NY rev (3m)-37.04%
Revenue NQ rev (1m)-33.83%
Revenue NQ rev (3m)-33.83%
Revenue NY rev (1m)-24.63%
Revenue NY rev (3m)-34.37%
Valuation
Industry RankSector Rank
PE 37.33
Fwd PE 25.84
P/S 1.83
P/FCF N/A
P/OCF 7.33
P/B 1.25
P/tB 1.34
EV/EBITDA 7.88
EPS(TTM)0.06
EY2.68%
EPS(NY)0.09
Fwd EY3.87%
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)0.31
OCFY13.64%
SpS1.23
BVpS1.8
TBVpS1.67
PEG (NY)0.84
PEG (5Y)3.3
Profitability
Industry RankSector Rank
ROA 2.79%
ROE 3.78%
ROCE 5.63%
ROIC 4.54%
ROICexc 5.31%
ROICexgc 5.69%
OM 10.11%
PM (TTM) 5.54%
GM 44.14%
FCFM N/A
ROA(3y)5.88%
ROA(5y)3.58%
ROE(3y)8.42%
ROE(5y)5.13%
ROIC(3y)7.97%
ROIC(5y)5.37%
ROICexc(3y)11.17%
ROICexc(5y)7.39%
ROICexgc(3y)12.1%
ROICexgc(5y)8%
ROCE(3y)9.89%
ROCE(5y)6.65%
ROICexcg growth 3Y40.95%
ROICexcg growth 5Y0.62%
ROICexc growth 3Y41%
ROICexc growth 5Y0.44%
OM growth 3Y45.12%
OM growth 5Y-4.7%
PM growth 3YN/A
PM growth 5Y0.19%
GM growth 3Y-2.25%
GM growth 5Y-0.15%
F-Score6
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA 1.06
Cap/Depr 265.04%
Cap/Sales 35.46%
Interest Coverage 4.13
Cash Conversion 106.08%
Profit Quality N/A
Current Ratio 1.71
Quick Ratio 1.71
Altman-Z 3.04
F-Score6
WACC8.54%
ROIC/WACC0.53
Cap/Depr(3y)223.62%
Cap/Depr(5y)158.87%
Cap/Sales(3y)27.46%
Cap/Sales(5y)21.34%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40%
EPS 3YN/A
EPS 5Y11.33%
EPS Q2Q%-300%
EPS Next Y44.5%
EPS Next 2Y48.66%
EPS Next 3Y51.2%
EPS Next 5Y20.59%
Revenue 1Y (TTM)0.47%
Revenue growth 3Y5.87%
Revenue growth 5Y10.7%
Sales Q2Q%-40.83%
Revenue Next Year-12.11%
Revenue Next 2Y4.12%
Revenue Next 3Y9.17%
Revenue Next 5YN/A
EBIT growth 1Y-28.1%
EBIT growth 3Y53.64%
EBIT growth 5Y5.49%
EBIT Next Year21.9%
EBIT Next 3Y21.38%
EBIT Next 5Y8.21%
FCF growth 1Y15.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y6.68%
OCF growth 3Y0.71%
OCF growth 5Y9.49%